PATIENT INQUIRY FOR NEO100 CLINICAL TRIAL
NEONC is conducting investigational clinical trials of NEO100 at select neuro-oncology centers in the United States.
A patient may qualify for this NEO100 study if the patient:
- Has a recurrent Grade 4 glioma (glioblastoma, glioblastoma multiforme)
- Has had prior surgery, radiation, and chemotherapy
- Is at least 18 years of age